Alert: New Earnings Report (2/29/24)-Pacira BioSciences Inc (NASDAQ: PCRX).
Pacira BioSciences Inc (NASDAQ: PCRX) has reported E.P.S. of $0.54 for its fourth fiscal quarter (ending December 31) versus $-0.22 for the same period a year ago. This performance was $-0.31 short of the consensus […]